Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Other Private Labelers Likely NBTY Suitors – Market Analyst

This article was originally published in The Tan Sheet

Executive Summary

Nutritional supplement manufacturer and marketer NBTY would be attractive to other private-label firms outside as well as within the supplement arena, but not to over-the-counter drug firms looking to expand into the field, according to an industry analyst

You may also be interested in...



NBTY Sees Double Digit Q1 Sales Growth; Efficiencies Drive Bump In Profits

Nutritional supplement manufacturer and marketer NBTY says a "mix of better selling products" gained "improved product placement" in U.S. markets as its Wholesale/U.S. Nutrition unit's 2007 first-quarter (ended Dec. 31) sales increased $22 million from the year-ago period to $247 million

US Market For OTC COVID-19 Tests Transitions From Unmet Demand To Multiple Choices

Abbott’s’s distribution of its BinaxNOW COVID-19 Ag Self Test to US retailers increases to three the number of OTC tests for the virus that CVS offers, along with Ellume’s and Labcorp’s test kits also available under EUAs granted by FDA.

ChromaDex Hits Consumer Brand Marketing Sweet Spot With Former Nestle Executive In Charge

Tru Niagen supplement firm names Fadi Karam CMO a little more than a month after it announced a distribution deal to put its nicotinamide riboside supplement on shelves at US Walmart stores.

Topics

UsernamePublicRestriction

Register

PS100362

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel